Skip to main content
. 2015 Jul 29;2015:189638. doi: 10.1155/2015/189638

Table 1.

Serum cytokine levels in MS cases.   

Analyte MS (ng/mL) Control (ng/mL)
IL-1α 6.6 ± 0.8 5.3 ± 2.2
IL1b 8.8 ± 0.9 6.6 ± 0.4
IL-1ra 23 ± 7.3 38 ± 17.2
IL-2Ra 320.3 ± 51.9  36.3 ± 4.1 
P < 0.04
IL-2 56.23 ± 32 78 ± 27
IL-3 82.0 ± 12.9 67.2 ± 13.4
IL4 87.8 ± 15.4 63.0 ± 18.6
IL-5 24.12 ± 17 33 ± 23
IL-7 5.2 ± 0.3 6.2 ± 0.8
IL-8 4.7 ± 0.5 6.6 ± 1.6
IL-9 9.7 ± 1.7 7.3 ± 1.4
IL10 73.6 ± 6.2 68.5 ± 10.2
IL-12p40 4005.7 ± 327.1  86.0 ± 6.1 
P < 0.00015
IL-12(p70) 90.2 ± 17.9 84.1 ± 8.6
IL-13 2.7 ± 0.3 2.1 ± 0.2
IL-15 85.0 ± 3.4 68.6 ± 4.6
IL-16 119.7 ± 33.9 241.1 ± 67.9
IL17A 103.79 ± 6.5  44.74 ± 6.3 
P = 0.001
IL17F 115.2 ± 8.3 44.7 ± 6.3
IL-18 118.3 ± 12.0 101.9 ± 24.3
IL21 184.3 ± 6.5 162.005 ± 16.1
IL22 163.5 ± 7.7 149.358 ± 18.7
IL23 481.4 ± 29.8  62.1517 ± 8.9 
P < 0.000003
IL25 36.8 ± 1.9 32.4 ± 1.7
IL31 230.5 ± 14.2 195.055 ± 29.8
IL33 1050.4 ± 291.0 683.6 ± 158.2
CCL2 915.9 ± 46.9  145.6 ± 23.0
P = 0.0000001
CCL3 73.8 ± 7.1  35.7 ± 4.1
P < 0.05
CCL4 64.2 ± 8.9 47.5 ± 13.2
CCL5 8743.6 ± 2219.2 2589.5 ± 248.3
CCL7 337.4 ± 55.2 119.8 ± 6.3
CCL11 220.3 ± 25.0 113.5 ± 28.8
CCL27 4674.9 ± 643.3  854.6 ± 51.0 
P < 0.05
CXCL1 342.9 ± 46.2 135.6 ± 40.6
CXCL9 2307.1 ± 338.7 2461.8 ± 301.6
CXCL10 1804.3 ± 264.6 732.2 ± 111.5
CXCL12 2575.6 ± 355.1 2582.4 ± 166.5
IFN-α2 59.8 ± 6.7 33.5 ± 8.0
INFγ 74.1 ± 4.1 77.3 ± 8.9
FGF basic 34 ± 24 56 ± 26
G-CSF 26.3 ± 2.9 19.7 ± 4.3
GM-CSF 45 ± 21 76 ± 34
HGF 1206.7 ± 164.1 931.7 ± 287.7
LIF 44.0 ± 7.9 29.2 ± 14.5
M-CSF 430.2 ± 41.7  37.3 ± 7.0 
P = 0.002
MIF 401.1 ± 32.9  148.6 ± 38.9 
P = 0.01
b-NGF 6.6 ± 0.4 6.7 ± 0.8
PDGF-bb 1256 ± 235 1462 ± 562
sCD40L 3592.9 ± 620.7 2756.0 ± 1007.3
SCF 230.5 ± 25.8 142.7 ± 18.9
SCGF-b 51782.6 ± 8900.2 46927.3 ± 7531.6
TNFα 39.8 ± 3.5 55.0 ± 5.3
TNF-β 10.4 ± 1.4 7.0 ± 1.5
TRAIL 252.3 ± 41.7 46.2 ± 10.0
VEGF 114.6 ± 12 74.4 ± 10.4